Enzyme research points to possible breast cancer target; Stem cell project could assist GI drug developers;

> Using X-ray crystallography, researchers determined the first crystal structures of an enzyme called DNA polymerase theta (POLQ), which may be a promising drug therapy target for inhibiting breast cancer. Release

> Scott Magness says he has figured out a way to isolate and grow thousands of elusive intestinal stem cells in the laboratory at time. The high-throughput process "promises to give scientists the ability to study stem cell biology and explore the origins of inflammatory bowel disease, intestinal cancers, and other gastrointestinal disorders." More

> Washington State University researchers say they discovered a mechanism by which omega-3 fatty acids can inhibit prostate cancer cells. The findings are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, possibly pointing the way to more effective anticancer drugs. Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.